FindTrial
Sign In

OROS Hydromorphone HCI

DRUG3 trials

Sponsors

Alza Corporation, DE, USA

Conditions

AnalgesiaAnalgesicsAnalgesics, OpioidOpioidOrthopedic ProceduresPainPain, Postoperative

Phase 2

A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative Pain
CompletedNCT00411307
Alza Corporation, DE, USAAnalgesia, Orthopedic Procedures, Pain, Postoperative
End: 2001-10-31Updated: 2010-04-27

Phase 3

A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain
CompletedNCT00410644
Alza Corporation, DE, USAAnalgesics, Opioid, Pain
End: 1999-02-28Updated: 2010-04-27
A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain
CompletedNCT00411034
Alza Corporation, DE, USAAnalgesics, Opioid, Pain
End: 1999-09-30Updated: 2010-04-27